Susquehanna International Group
NYMX

Susquehanna International Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Susquehanna International Group’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-41,914
Closed -$7.96K – 13489
2023
Q2 		$7.96K Buy
41,914
+2,293
+6% +$903 ﹤0.01% 11789
2023
Q1 		$13.5K Sell
39,621
-10,077
-20% -$4.09K ﹤0.01% 12148
2022
Q4 		$14.8K Buy
49,698
+14,482
+41% +$5.24K ﹤0.01% 11852
2022
Q3 		$15K Buy
35,216
+8,689
+33% +$3.46K ﹤0.01% 12709
2022
Q2 		$12K Sell
26,527
-38,236
-59% -$35.2K ﹤0.01% 12485
2022
Q1 		$82K Sell
64,763
-1,225
-2% -$1.89K ﹤0.01% 12040
2021
Q4 		$86K Sell
65,988
-24,051
-27% -$38.4K ﹤0.01% 12245
2021
Q3 		$185K Buy
90,039
+55,077
+158% +$97.6K ﹤0.01% 11582
2021
Q2 		$55K Buy
34,962
+1,454
+4% +$2.69K ﹤0.01% 12274
2021
Q1 		$74K Buy
33,508
+4,720
+16% +$12.4K ﹤0.01% 11954
2020
Q4 		$71K Sell
28,788
-1,346
-4% -$2.97K ﹤0.01% 10645
2020
Q3 		$74K Buy
30,134
+12,407
+70% +$36.1K ﹤0.01% 10074
2020
Q2 		$63K Sell
17,727
-315,736
-95% -$999K ﹤0.01% 9688
2020
Q1 		$780K Buy
333,463
+229,318
+220% +$644K ﹤0.01% 5944
2019
Q4 		$229K Buy
104,145
+90,270
+651% +$178K ﹤0.01% 8525
2019
Q3 		$26K Buy
+13,875
New +$24.3K ﹤0.01% 9915
2019
Q2 		– Sell
-10,844
Closed -$19K – 11022
2019
Q1 		$21K Sell
10,844
-120,509
-92% -$256K ﹤0.01% 8589
2018
Q4 		$172K Sell
131,353
-157,211
-54% -$288K ﹤0.01% 7875
2018
Q3 		$710K Buy
288,564
+78,692
+37% +$232K ﹤0.01% 5904
2018
Q2 		$705K Buy
209,872
+91,365
+77% +$351K ﹤0.01% 6119
2018
Q1 		$501K Sell
118,507
-67,668
-36% -$235K ﹤0.01% 6629
2017
Q4 		$614K Buy
186,175
+107,045
+135% +$390K ﹤0.01% 6230
2017
Q3 		$302K Buy
+79,130
New +$300K ﹤0.01% 7383
2017
Q2 		– Sell
-207,324
Closed -$851K – 10012
2017
Q1 		$753K Buy
207,324
+138,980
+203% +$457K ﹤0.01% 5728
2016
Q4 		$182K Sell
68,344
-3,629
-5% -$11.3K ﹤0.01% 8722
2016
Q3 		$235K Buy
71,973
+47,281
+191% +$155K ﹤0.01% 7321
2016
Q2 		$83K Sell
24,692
-36,561
-60% -$89.8K ﹤0.01% 8105
2016
Q1 		$149K Sell
61,253
-2,475
-4% -$5.85K ﹤0.01% 8216
2015
Q4 		$209K Buy
63,728
+27,011
+74% +$90.6K ﹤0.01% 8351
2015
Q3 		$126K Buy
+36,717
New +$85.4K ﹤0.01% 9028
2015
Q2 		– Sell
-10,800
Closed -$9K – 10568
2015
Q1 		$9K Sell
10,800
-772
-7% -$364 ﹤0.01% 9315
2014
Q4 		$5K Sell
11,572
-25,916
-69% -$55.3K ﹤0.01% 9540
2014
Q3 		$163K Buy
37,488
+20,835
+125% +$102K ﹤0.01% 8840
2014
Q2 		$82K Sell
16,653
-17,239
-51% -$88.8K ﹤0.01% 9476
2014
Q1 		$185K Sell
33,892
-4,955
-13% -$28.7K ﹤0.01% 8293
2013
Q4 		$236K Sell
38,847
-10,714
-22% -$73K ﹤0.01% 7999
2013
Q3 		$328K Sell
49,561
-43,853
-47% -$286K ﹤0.01% 7081
2013
Q2 		$481K Buy
+93,414
New +$473K ﹤0.01% 6100

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

Susquehanna International Group's NYMX Position: Q3 2023 in Review

Susquehanna International Group sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 41,914 shares — an estimated $7.96K sold.

Susquehanna International Group first reported a position in NYMX in Q2 2013 and held it in 38 quarters. The position peaked at $780K in Q1 2020. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Susquehanna International Group reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 41,914 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $7.96K.
  • Susquehanna International Group first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 38 quarters.
  • Susquehanna International Group's Nymox Pharmaceutical Corp position peaked at $780K in Q1 2020.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.